The list of prohibited substances and methods in sport: Structure and review process by the world anti-doping agency

Journal of Analytical Toxicology

Volumn 35, Issue 9, 2011, Pages 608-612

  Mazzoni, Irene ^a   Barroso, Osquel ^a   Rabin, Olivier ^a  

^a World Anti Doping Agency (WADA)   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ANABOLIC AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CANNABINOID; CENTRAL STIMULANT AGENT; DIURETIC AGENT; GLUCOCORTICOID; GROWTH FACTOR; HORMONE ANTAGONIST; ILLICIT DRUG; NARCOTIC AGENT; PEPTIDE HORMONE; PERFORMANCE ENHANCING SUBSTANCE;

ARTICLE; DOPING; DRUG APPROVAL; DRUG SURVEILLANCE PROGRAM; HEALTH CARE ORGANIZATION; HUMAN; SPORT;

DOPING IN SPORTS; HISTORY, 19TH CENTURY; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; INTERNATIONAL AGENCIES; ORGANIZATIONS, NONPROFIT; PERFORMANCE-ENHANCING SUBSTANCES; POLICY MAKING; SUBSTANCE ABUSE DETECTION;

EID: 82855181664     PISSN: 01464760     EISSN: 19452403     Source Type: Journal    
DOI: 10.1093/anatox/35.9.608     Document Type: Article

References (21)

1. R.K. Müller. History of doping and doping control. Handb. Exp. Pharmacol. 195: 1-23 (2010).
2. M. Verroken. Drug use and abuse in sport. Baillières Best Pract. Res. Clin. Endocrinol. Metab. 14: 1-23 (2000).
3. P.C. Carpenter. Performance-enhancing drugs in sport. Endocrinol. Metab. Clin. North Am. 36: 481-495 (2007).
4. M. Kamber and P.E. Mullis. The worldwide fight against doping: from the beginning to theWorld Anti-Doping Agency. Endocrinol. Metab. Clin. North Am. 39: 1-9 (2010).
5. BBC-Sport. Festina Affair: A timeline. http://news.bbc.co.uk/sport2/hi/other_sports/988530.stm (accessed January 2011).
6. Sports Illustrated. Festina team expelled from tour in drug scandal. http://sportsillustrated.cnn.com/cycling/1998/tourdefrance/news/1998/07/17/festina_expelled/ (accessed January 2011).
7. World Anti-Doping Code 2003.World Anti-Doping Agency, Montreal, Canada, 2003.
8. World Anti-Doping Code 2009.World Anti-Doping Agency, Montreal, Canada, 2009.
9. World Anti-Doping Agency. Prohibited List Committee. http://www.wada-ama.org/en/About-WADA/Governance/Health-Medical--Research-Committee/List-Working-Committee/ (accessed January 2011).
10. World Anti-Doping Agency. Health, Medical and Research Committee. http://www.wada-ama.org/en/About-WADA/Governance/Health-Medical--Research-Committee/ (accessed January 2011).
11. World Anti-Doping Agency. Executive Committee. http://www.wada-ama.org/en/About-WADA/Governance/Executive-Committee/ (accessed January 2011).
12. World Anti-Doping Code 2009.World Anti-Doping Agency, Montreal, QC, Canada, 2009, p 29.
13. Le Monde. Les nouvelles drogues se multiplient en Europe. http://www.lemonde.fr/planete/article/2010/05/06/les-nouvellesdrogues-se-multiplient-en-europe_1347499_3244.html (accessed January 2011).
14. World Anti-Doping Agency. List of Prohibited Substances and Methods. http://www.wada-ama.org/en/Science-Medicine/Prohibited-List/ (accessed January 2011).
15. World Anti-Doping Code 2003.World Anti-Doping Agency, Montreal, Canada, 2003, p 15
16. World Anti-Doping Code 2009.World Anti-Doping Agency, Montreal, Canada, 2009, p 30.
17. World Anti-Doping Agency. The Monitoring Program. http://www.wada-ama.org/en/Science-Medicine/Prohibited-List/ (accessed January 2011).
18. H. Hasegawa, M.F. Piacentini, S. Sarre, Y. Michotte, T. Ishiwata, and R. Meeusen. Influence of brain catecholamines on the development of fatigue in exercising rats in the heat. J. Physiol. 586: 141-149 (2008).
19. B. Roelands, H. Hasegawa, P.Watson, M.F. Piacentini, L. Buyse, G. De Schutter, and R. Meeusen. The effects of acute dopamine reuptake inhibition on performance. Med. Sci. Sports Exerc. 40: 879-885 (2008).
20. B. Roelands, H. Hasegawa, P.Watson, M.F. Piacentini, L. Buyse, G. De Schutter, and R. Meeusen. Performance and thermoregulatory effects of chronic bupropion administration in the heat. Eur. J. Appl. Physiol. 105: 493-498 (2009).
21. P. Watson, H. Hasegawa, B. Roelands, M.F. Piacentini, R. Looverie, and R. Meeusen. Acute dopamine/noradrenaline reuptake inhibition enhances human exercise performance in warm, but not temperate conditions. J. Physiol. 565: 873-883 (2005).